Related Experiment Video
Updated: Aug 14, 2025

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Predictive models for endoscopic disease activity in patients with ulcerative colitis: Practical machine
Xiaojun Li1, Lamei Yan1,2, Xuehong Wang1
1Department of Gastroenterology, The Second Xiangya Hospital of Central South University, Research Center of Digestive Disease, Central South University, Changsha, China.
Machine learning models can predict ulcerative colitis (UC) endoscopic activity non-invasively, using clinical and lab data. This approach may reduce the need for frequent colonoscopies in UC patients.
Area of Science:
- Gastroenterology
- Medical Informatics
- Computational Biology
Background:
- Endoscopic monitoring is crucial for ulcerative colitis (UC) management.
- Current non-invasive methods lack effectiveness in predicting endoscopic disease activity.
- Reducing endoscopic procedures and associated costs is a clinical need.
Purpose of the Study:
- To develop and validate machine learning (ML) models for predicting endoscopic disease activity in UC patients.
- To establish a non-invasive tool for assessing UC severity.
- To potentially decrease the frequency of invasive endoscopic examinations.
Main Methods:
- Retrospective study of 420 UC patients (January 2016 - January 2021).
- Collected 39 clinical and laboratory variables, categorized by Mayo Endoscopic Score (MES) or Ulcerative Colitis Endoscopic Index of Severity (UCEIS).
- Applied logistic regression and four ML algorithms (Random Forests, XGBoost), with feature selection and SMOTE, evaluated using AUC, accuracy, sensitivity, precision, and F1 score. SHAP for interpretability.
Main Results:
- Random Forests (23 variables) achieved AUC 0.8192 for MES prediction.
- XGBoost (21 variables) achieved AUC 0.8006 for UCEIS prediction.
- Albumin, rectal bleeding, and CRP/ALB ratio were key predictors identified by SHAP analysis.
Conclusions:
- ML models offer a promising non-invasive method for predicting endoscopic disease activity in UC.
- Random Forests and XGBoost demonstrate suitability for data-driven endoscopic activity prediction in UC.
- This approach could aid in optimizing patient management and reducing healthcare burdens.
More Related Videos
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Drugs for Treatment of Ulcerative Colitis in IBD